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Background
The last few years have brought rapid growth in the
number of Virtual Microscopes (VM) and the promo-
tion of digital histology. In this digital era, it is natural
to assist in the transportation of histology imaging into
computer technology support. We have also assisted in
a quick and precise race towards improved technology
capable of acquiring detailed digital images which realis-
tically report the original slide for easy consultation
[1,2].
The advanced technology herein proposed aims at
being a sophisticated imaging archive. Digitally scanning
slides however, does not give additional information to
the vision of tissue structures, even with high resolution
or improved colour and image precision. We can now
say that high enlargement microscopic observation can
only give same details to structures visible to the eye
directly through the microscope. This means that when
VMs are used in a correct manner they are capable of
giving significant progress to highlighting, not quantify-
ing, a critical field in applying technology specific to com-
puterised measuring. The potential to improve precision
and objectivity of measurements can be achieved with
additional technical equipment. The aim of this study is
to present a machine invented with a calculation poten-
tial to facilitate the work of the observer in a medical
practice, not only in terms of easy retrieval of images but
also as an instrument for the automatic analysis of digital
histology. The “Metrizer” aims at supplying precise and
objective descriptions and measurements of the specimen
under observation. These descriptions do not substitute
the pathologist but they should assist him/her to assert
with objectivity and safety the entity of the observed
pathology [3-8].
Material and methods
The “Metrizer” (Figure 1) is an automatic, compact
machine composed of a lens for microscopic observa-
tion, digital cameras, a movement device and a compu-
ter complete with software to control machine
movement and image analysis. With these components
the machine facilitates consultation of histological pre-
parations (virtual microscope - slide scanner function)
and supplies objective numeric data regarding the state
of the tissue harbouring diverse diseases without causing
fatigue or human error.
Using the Slide Scanner function it enables to automa-
tically digitalise the entire histological slide in high defi-
nition and makes it easily accessible in the digital
archive.
Furthermore the Metrizer gives: 1) custom image ana-
lysis algorithms, 2) objective data obtained from ele-
ments present in the tissue, and 3) what can be called
an Automatic Diagnosis. This diagnosis, preset for each
pathology, is generated by an expert system shaped on a
series of data that has been preloaded once diagnosis is
known. The expert system referral cut-off is then calcu-
lated from these data. The automatic diagnosis permits
to completely abolish operator subjectivity, from image
capture to the print-out of final report (Figure 2).
Testing
The validation process of the Metrizer was made by
comparing measurements obtained with this machine
on histological slides taken from a series of 120 patients
previously achieved by the automatic reading software
of the preliminary model of automatic analysis, consist-
ing of a motorised microscope Leica DMLA [6].
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Model validation
Complete histological specimen of hepatic biopsies of
235 patients affected by chronic inflammation were
acquired, analyzed and compared with clinical data and
semiquantitative evaluations. By arranging data and
comparing them with the main methods of evaluation
in use, cut-offs were located which enabled to oppor-
tunely delineate the expert system. From these retro-
spective cut-offs descriptions of a further 200 patients,
making a total of 435 cases analysed with the so-called
‘Model’, were prospectively generated and verified [7].
Validation of the Metrizer
120 cases coming from the validation series of the
Model, which necessitated several months of work on
the old system, were then examined in just a few days
by the Metrizer and a high level of correlation was
reached. Proof of the validity of this new, ultra rapid
machine was had by comparing the groups of new data
with those obtained by the already validated but much
slower semiautomatic Model. In fact the Metrizer car-
ries out all the steps in a few minutes without involving
the operator, so that the method which was previously
only used for research can be really applied to routine
clinical practice in support of the evaluations of the
pathologist.
Results
Comparison of data obtained with the Model with those
of new data rapidly achieved by the Metrizer was made
on the basis of percentage area values and tectonic
index of the fibrosis, and of the inflammatory basin
located in the biopsies of the 120 cases available. A dou-
ble evaluation is thus obtained, from both the old and
the new system. The catalogues of located objects in the
two different systems were also compared.
The values are very sensitive to intense light and mag-
nifying lens, however by correctly calibrating the
machine it is possible to achieve reproducible data with
very low margin of instrumental error. The comparison
between the two machines can be seen in Table 1. Cor-
relation coefficient between the two sets of data are
R=0,94 in fibrosis quantification and R=0,96 in the case
of inflammatory basin.
Figure 1 The Metrizer Prototypical version of the Metrizer, used in this work and for presentation purposes
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Histological Metrizer (shortened to Metrizer) described
herein, is a machine capable of automatically measuring
the state of opportunely stained histological specimens in
a decidedly more accurate manner than all current meth-
ods of evaluation.
The application of quantitative methods in a medical
setting faces numerous difficulties because these disci-
plines involve natural, complex and irregular objects and
phenomena, many with characteristics that lead them to
be classified as fractal objects [9,10]. Their evaluation
describable with traditional linear mathematics and
Euclidean geometry, can at times give results that are so
distant from reality as to seem caricatures rather than
metric descriptions of the object under examination.
However, these objects can be described and, with sui-
table non-Euclidean geometry, can also be measured
with automated calculus technology for operational
complexity that requires measurement of their complex
structure and interpreted with basics of physics different
from those of statics on which the greater part of medi-
cal disciplines is founded.
In order to obtain measurements as close as possible
to reality, our Laboratory of Quantitative Medicine uses
fractal geometry to correct the metric measurements of
irregular objects.
Conclusions
The Metrizer changes the method of examining liver
biopsies since it resolves fundamental problems to
measure microscopic structures. For the first time it
enables evaluation with a scalar number, in an abso-
lutely objective and repeatable manner, the size of the
structures that determine the state of the diseased
liver. It must be stressed that histological diagnosis of
hepatic disease is currently entrusted to the interpre-
tive ability of the pathologist, but it also depends on
his level of fatigue.
The automation of the Metrizer standardizes measure-
ment and eliminates operator fatigue, it reads elements
which are completely invisible to the human eye and
has an unlimited calculation potential.
Furthermore, the Metrizer transforms clinical
thought (reasoning) into technological terms and gives
both a description and a computer diagnosis, which
Table 1 Model-Metrizer Comparison
A% Fibrosis A% Inflammation
Series Model Metrizer Model Metrizer
Min 0,22% 0,35% 0,02% 0,04%
Max 8,32% 14,44% 11,77% 11,48%
Mean 2,23% 2,99% 1,87% 1,88%
St. Dev. 1,69% 2,33% 2,13% 2,14%
Relative Median Error (Log): 9,14% 7,23%
The table shows that the relative median difference of the calculated values
was less than 10%. The highest error can be found comparing cases of
fibrosis, which reaches 9,14%. This is due to the diverse composition of the
CCD of the Model’s cameras compared with those of the Metrizer, which loses
some details in fibrosis. The video camera of the Metrizer have an higher
colour definition so as to take even smaller details.
Figure 2 Example of Metrizer output
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it obtains using new geometries such as fractals for
measuring irregular shapes of scars (collagen islets),
fragments of the biliary and the neoangiogenic micro-
vascular network. Being able to measure the real deter-
minants of chronic inflammatory disease dynamics
of the liver, means understanding the amount of
damage the liver has suffered and refines therapeutic
choices, making a more rigorous assessment of its
effects.
The totally computerized evaluation entrusted to the
Metrizer, i.e. of the liver, completely excludes the sub-
jective intervention of the operator when supplying a
“metric hepatogram” where a description is given of the
extent of inflammation and fibrosis (scarring), biliary
or neoangiogenic regeneration and tissue disorder is
quantitatively assessed with a tectonic index. All this is
achieved in just a few minutes.
Everyone involved in biologic and medical research
will, at some point, come across complex situations
which escape thorough description.
All the methods elaborated in the medical world aim
at offering adequate procedures with which to locate,
define and correlate the largest number of aspects
regarding changes in characteristics of the specimen
under observation; rather like saying of lesions on
organs and organisms determined by natural causes.
One way to define tissutal lesions is to study the quality
and quantity of the processes causing them and the
descriptions of the differences between type, size and
intensity of the lesions they cause.
The Metrizer was created to meet the needs of matur-
ity gained in hepatology.
To have measurements which can be repeated any-
where using the same method, means the beginning of a
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